The Highwire with Del Bigtree - HEPATITIS B VACCINE SAFETY TESTED FOR JUST FIVE DAYS

Episode Date: February 6, 2023

Dr. Stanley Plotkin, widely considered the world’s leading authority on vaccines, is questioned by ICAN Lead Attorney Aaron Siri, Esq. about the pre-licensure safety testing of the Hepatitis B vaccine, a vaccine given to babies in their first days of life in the U.S. FDA Documents reveal the vaccine was followed for safety for just five days in the trials. #PlotkinOnVaccines #PlotkinDeposition #HepBVaccineBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Dr. Plotkin, earlier you testified that there are two Hep B vaccines in the market, one by Glaxo G.SK, that's Enderix B, and the other one is by Merck, recombavax, HB, right? Yes. This is the product, the manufacturer insert for recombavax HB, correct? Yes. And the clinical trial experience would be found in Section 6.1, correct? Correct. Dr. Plotkin? Yes.

Okay. In section 6.1, when you look at the clinical trials that were done pre-licensure for KamaVax-HB, how long does it say that safety was monitored after each dose? Uh, let's see, five days. Is five days long enough to detect an autoimmune issue that arises after five days? Uh, no. Is five days long enough to detect any neurological disorder? that arose from the vaccine after five days?

No. There is no control group, correct? It does not mention any control group, no. If you turn to section 6.2, under immune system disorders, does it say that there were reports of hypersensitive reactions, including anaphylactic, anaphylactoid reactions, bronchospasms, and uticaria,

having been reported within the first few hours after vaccination? Yes. Have there been reports of hypersensitivity syndrome? Yes, that's what it states. Reports of arthritis? It is mentioned. It also reports autoimmune diseases including systemic lupus, erythematosis, lupus-like syndrome, vasculitis, and polyteritis. tyrritis, Nidoza as well, correct?

Yes, that's what it states. And also it states that under the nervous system disorders, it states that after that there have been reports of Guillambore syndrome, correct? Yes. As well as multiple sclerosis, exacerbation of multiple sclerosis, myelitis, including transverse myelitis, seizure, febrile seizure, peripheral seizure, perific Neuropathy, including Bells Palsy, radiculopathy. Radiculopathy.

Thank you very much. Muscle weakness, hypopathy, and encephalitis, correct? Correct. These are events that are reported after vaccination, and as we've just discussed, in order to establish whether it's causal between the vaccine and the condition, You need a randomized placebo-controlled study.

But that was not done for this hepatitis B vaccine before licensure, was it? No. Okay. And given that the vaccine now appears on the CDC's recommended list, isn't it true that it would now be considered unethical to conduct such a study today? It would be, yes, it would be ethically difficult.